NCT05334485View on ClinicalTrials.gov

Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Postoperative Ileus
Interventions
DRUG

Pyridostigmine Bromide

Oral 60mg pyridostigmine bromide

OTHER

Placebo

Oral starch placebo

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Main Campus, Cleveland

All Listed Sponsors
lead

Stefan Holubar MD MS FACS, FASCRS

OTHER